Wave Life Sciences Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WVE research report →
Companywww.wavelifesciences.com
Wave Life Sciences Ltd. , a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins, or modulate protein expression.
- CEO
- Paul Bolno
- IPO
- 2015
- Employees
- 287
- HQ
- Singapore, SG
Price Chart
Valuation
- Market Cap
- $1.19B
- P/E
- -6.75
- P/S
- 16.59
- P/B
- 2.42
- EV/EBITDA
- -3.64
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 93.79%
- Op Margin
- -274.21%
- Net Margin
- -255.70%
- ROE
- -56.41%
- ROIC
- -36.32%
Growth & Income
- Revenue
- $42.73M · -60.55%
- Net Income
- $-204,378,000 · -110.68%
- EPS
- $-1.21 · -72.86%
- Op Income
- $-215,383,000
- FCF YoY
- -23.38%
Performance & Tape
- 52W High
- $21.73
- 52W Low
- $5.02
- 50D MA
- $8.39
- 200D MA
- $10.13
- Beta
- -1.32
- Avg Volume
- 4.70M
Get TickerSpark's AI analysis on WVE
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 9, 26 | Wright Christopher I | other | 0 |
| Apr 9, 26 | Wright Christopher I | other | 300,000 |
| Apr 9, 26 | Wright Christopher I | other | 273,750 |
| Apr 9, 26 | Ingelsson Erik | other | 0 |
| Apr 9, 26 | Ingelsson Erik | other | 350,000 |
| Apr 9, 26 | Ingelsson Erik | other | 200,000 |
| Apr 9, 26 | Ingelsson Erik | other | 273,750 |
| Mar 30, 26 | RA CAPITAL MANAGEMENT, L.P. | buy | 971,091 |
| Mar 27, 26 | RA CAPITAL MANAGEMENT, L.P. | buy | 2,495,623 |
| Mar 26, 26 | RA CAPITAL MANAGEMENT, L.P. | buy | 351,224 |
Our WVE Coverage
We haven't published any research on WVE yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate WVE Report →